High-affinity dextromethorphan binding sites in guinea pig brain. II. Competition experiments.

Area of Science:

• Pharmacology
• Neuroscience
• Drug Discovery

Background:

• Dextromethorphan (DM) is a centrally acting antitussive.
• The precise binding sites and interactions of DM in the brain are not fully understood.

Purpose of the Study:

• To characterize the binding sites of dextromethorphan in the central nervous system.
• To investigate the affinity of various compounds, including antitussives and other CNS-active drugs, for DM binding sites.

Main Methods:

• Stereoselective competition binding assays using tritiated dextromethorphan ([3H]DM).
• Inhibition studies with various opiate agonists/antagonists, antitussives, neurotransmitters, antidepressants, and neuroleptics.
• Comparison of binding characteristics in guinea pig, rat, and mouse brain, as well as liver homogenates.

Main Results:

• DM binding is stereoselective, with levomethorphan being significantly weaker.
• Centrally acting antitussives (caramiphen, carbetapentane, dimethoxanate, pipazethate) show high affinity (nanomolar range) for DM sites.
• Noscapine and diphenylhydantoin enhance DM binding.
• No correlation was found between DM binding and known neurotransmitter sites, tricyclic antidepressant sites, or biogenic amine uptake sites.
• Certain phenothiazine neuroleptics and antidepressants inhibit DM binding.
• Species-dependent variations in antitussive potencies were observed.
• Peripheral [3H]DM binding sites in liver show differences compared to central sites.

Conclusions:

• Central DM binding sites exhibit high affinity for non-narcotic antitussives, suggesting a potential role in their mechanism of action.
• The binding profile of DM sites is distinct from known neurotransmitter and drug-binding sites.
• Further research is needed to elucidate the exact nature and function of central DM binding sites.